![](/img/cover-not-exists.png)
Camrelizumab plus gemcitabine, vinorelbine and pegylated liposomal doxorubicin in relapsed/refractory primary mediastinal B-cell lymphoma: a single-arm, open-label, phase 2 trial
Mei, Qian, Zhang, Wen-ying, Liu, Yang, Yang, Qingming, Rasko, John EJ, Nie, Jing, Liu, Jiejie, Li, Xiang, Dong, Liang, Chen, Meixia, Zhang, Yan, Shi, Lu, Wu, Huitao, Han, WeidongJournal:
Clinical Cancer Research
DOI:
10.1158/1078-0432.CCR-20-0514
Date:
June, 2020
File:
PDF, 4.29 MB
2020